These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Structure of the human Nac1 POZ domain. Stead MA; Carr SB; Wright SC Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 May; 65(Pt 5):445-9. PubMed ID: 19407373 [TBL] [Abstract][Full Text] [Related]
5. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain. Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154 [TBL] [Abstract][Full Text] [Related]
6. NAC1, a POZ/BTB protein that functions as a corepressor. Korutla L; Wang P; Jackson TG; Mackler SA Neurochem Int; 2009; 54(3-4):245-52. PubMed ID: 19121354 [TBL] [Abstract][Full Text] [Related]
7. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. Huynh KD; Bardwell VJ Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158 [TBL] [Abstract][Full Text] [Related]
8. Structure of the wild-type human BCL6 POZ domain. Stead MA; Rosbrook GO; Hadden JM; Trinh CH; Carr SB; Wright SC Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Dec; 64(Pt 12):1101-4. PubMed ID: 19052359 [TBL] [Abstract][Full Text] [Related]
9. A beta-sheet interaction interface directs the tetramerisation of the Miz-1 POZ domain. Stead MA; Trinh CH; Garnett JA; Carr SB; Baron AJ; Edwards TA; Wright SC J Mol Biol; 2007 Nov; 373(4):820-6. PubMed ID: 17880999 [TBL] [Abstract][Full Text] [Related]
10. Identification of an atypical interaction site in the BTB domain of the MYC-interacting zinc-finger protein 1. Orth B; Sander B; Möglich A; Diederichs K; Eilers M; Lorenz S Structure; 2021 Nov; 29(11):1230-1240.e5. PubMed ID: 34186024 [TBL] [Abstract][Full Text] [Related]
12. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Dhordain P; Albagli O; Lin RJ; Ansieau S; Quief S; Leutz A; Kerckaert JP; Evans RM; Leprince D Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10762-7. PubMed ID: 9380707 [TBL] [Abstract][Full Text] [Related]
13. The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain. Evans SE; Goult BT; Fairall L; Jamieson AG; Ko Ferrigno P; Ford R; Schwabe JW; Wagner SD PLoS One; 2014; 9(3):e90889. PubMed ID: 24595451 [TBL] [Abstract][Full Text] [Related]
14. Insights into strand exchange in BTB domain dimers from the crystal structures of FAZF and Miz1. Stogios PJ; Cuesta-Seijo JA; Chen L; Pomroy NC; Privé GG J Mol Biol; 2010 Jul; 400(5):983-97. PubMed ID: 20493880 [TBL] [Abstract][Full Text] [Related]
15. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B. Deltour S; Guerardel C; Leprince D Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14831-6. PubMed ID: 10611298 [TBL] [Abstract][Full Text] [Related]
16. Functional interaction of HTLV-1 tax protein with the POZ domain of the transcriptional repressor BCL6. Dean J; Hashimoto K; Tsuji T; Gautier V; Hall WW; Sheehy N Oncogene; 2009 Oct; 28(42):3723-34. PubMed ID: 19701248 [TBL] [Abstract][Full Text] [Related]
17. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions. Melnick A; Ahmad KF; Arai S; Polinger A; Ball H; Borden KL; Carlile GW; Prive GG; Licht JD Mol Cell Biol; 2000 Sep; 20(17):6550-67. PubMed ID: 10938130 [TBL] [Abstract][Full Text] [Related]
18. Overexpression, purification, characterization, and crystallization of the BTB/POZ domain from the PLZF oncoprotein. Li X; Lopez-Guisa JM; Ninan N; Weiner EJ; Rauscher FJ; Marmorstein R J Biol Chem; 1997 Oct; 272(43):27324-9. PubMed ID: 9341182 [TBL] [Abstract][Full Text] [Related]
19. POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation. Pero R; Palmieri D; Angrisano T; Valentino T; Federico A; Franco R; Lembo F; Klein-Szanto AJ; Del Vecchio L; Montanaro D; Keller S; Arra C; Papadopoulou V; Wagner SD; Croce CM; Fusco A; Chiariotti L; Fedele M J Biol Chem; 2012 May; 287(22):18308-17. PubMed ID: 22493480 [TBL] [Abstract][Full Text] [Related]
20. BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor. Okabe S; Fukuda T; Ishibashi K; Kojima S; Okada S; Hatano M; Ebara M; Saisho H; Tokuhisa T Mol Cell Biol; 1998 Jul; 18(7):4235-44. PubMed ID: 9632807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]